Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Genenta to present preliminary Phase I/II clinical data on Temferon™ in glioblastoma multiforme at Chardan’s 4th Annual Genetic Medicines Conference
-
uniQure to Participate in Multiple Upcoming Industry Conferences in October
-
Translate Bio to Participate in Upcoming Investor Conferences
-
Taysha Gene Therapies Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
VBL Therapeutics to Present at the Chardan 4th Annual Genetic Medicines Conference
-
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
-
Ocugen to Participate in a Virtual Fireside Chat at the Chardan Genetic Medicines Conference
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
-
Tmunity to Present at Upcoming Investor Conferences
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
-
Aruvant to Present at Investor and Scientific Conferences in October
-
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
-
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
-
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Dicerna to Participate in the Chardan 4th Annual Genetic Medicines Conference
-
DTx Pharma to Present at the Chardan Virtual 4th Annual Genetic Medicines Event
-
Avidity Biosciences to Present at the Virtual Chardan 4th Annual Genetic Medicines Conference 2020
-
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference
-
Moderna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
-
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
-
Arbutus to Participate in Virtual Fireside Chat at Chardan’s 4th Annual Genetic Medicines Conference
-
NeuBase Therapeutics to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th
-
Intellia Therapeutics to Present at Chardan’s Virtual 4th Annual Genetic Medicines Conference
-
Arbutus to Participate in Virtual Fireside Chat at Chardan’s 4th Annual Genetic Medicines Conference
-
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
-
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
-
5 Penny Stocks To Watch With Recent & Upcoming Biotech Events
-
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020
-
LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020
-
Prevail Therapeutics to Present at Upcoming Investor Conferences
-
Prevail Therapeutics to Present at Upcoming Investor Conferences
-
Cabaletta Bio to Present at Upcoming Investor Conferences in October
-
Cabaletta Bio to Present at Upcoming Investor Conferences in October
-
Passage Bio to Participate in Upcoming October Investor Conferences
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
-
AVROBIO to Present at Two Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming October Investor Conferences
-
REGENXBIO to Participate in Upcoming Investor Conferences
-
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
-
Taysha Gene Therapies (TSHA) IPO Opens 11% Higher
-
Krystal Biotech to Present at Upcoming Investor Conferences
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
Taysha Gene Therapies Announces Pricing of Initial Public Offering
-
Homology Medicines to Participate in Upcoming Conferences
-
UPDATE: Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral
-
Tottenham Acquisition I Limited Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Clene Nanomedicine, Inc.
-
Immunovant Announces Closing of $200.0 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Kriya Therapeutics To Present At Upcoming Healthcare Conferences

